Venous Thromboembolism Clinical Trials

15 studies are recruiting for venous thromboembolism in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

  1. Computerized Registry of Patients With Venous Thromboembolism (RIETE)

    The Computerized Registry of Patients with Venous Thromboembolism (RIETE) is a multidisciplinary Project initiated in march 2001 and consisting in obtaining an extensive data registry of consecutive patients with venous thromboembolism. The main objective is to provide information on the Internet t…

    Stage
    Not phased
    Ages
    Any age
    Site
    College of Medicine - Jacksonville University of Florida, Jacksonville, Florida
    Locations
    297 in total
    Run by
    Manuel Monreal
  2. Statins to Prevent Cancer Associated Blood Clots

    Patients with cancer are at high risk for life-threatening venous thromboembolism (VTE) yet rarely receive anticoagulant prophylaxis due to bleeding risks. Thus, effective prophylaxis in oncology requires a method to reduce VTE without increasing hemorrhage. The primary aim of the Statin Therapy to…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    City of Hope, Irvine, California
    Locations
    9 in total
    Run by
    Brigham and Women's Hospital
  3. DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

    This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Man…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Honor Health, Scottsdale, Arizona
    Locations
    64 in total
    Run by
    Inari Medical
  4. Evaluation of the SCALED (SCaling AcceptabLE cDs)

    This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previou…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Minnesota, Minneapolis, Minnesota
    Run by
    University of Minnesota
  5. Aspiration Thrombectomy Using the Symphony or Prodigy System

    The study is designed to evaluate the short-term and long-term clinical performance and safety of the Symphony and Prodigy thrombectomy systems used in endovascular procedures across the peripheral or pulmonary vasculature.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Huntsville Hospital, Huntsville, Alabama
    Locations
    8 in total
    Run by
    Imperative Care, Inc.
  6. Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

    The purpose of this study is to find out whether a software tool, ctDNA/VTE (Venous Thromboembolism) risk score model, is an effective way to predict the likelihood of VTE coming back in people who have received anticoagulant treatment.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Cancer Center Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey
    Locations
    8 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  7. Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

    This prospective, observational, post-market study will be performed to collect patient-level data on the Celect Platinum Vena Cava Filter Sets and the Günther Tulip Vena Cava Filter Retrieval Set to confirm continued safety and performance of the devices throughout their expected lifetime and cont…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Cedars-Sinai Medical Center, Los Angeles, California
    Locations
    7 in total
    Run by
    Cook Research Incorporated
  8. Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty

    This research study is attempting to answer the question of whether 81 mg aspirin once daily is as effective as 81 mg aspirin twice daily in preventing blood clots after total joint replacement surgery.

    Stage
    Phase 2
    Ages
    19 and older
    Site
    University of Miami Hospital, Miami, Florida
    Run by
    University of Miami
  9. Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)

    Hospitalized medical patients have an increased risk of venous thromboembolism (VTE) across the continuum of care, including after hospital discharge. In the APEX Trial of hospitalized patients with acute medical illness, extended-duration post-discharge thromboprophylaxis with oral betrixaban redu…

    Stage
    Not phased
    Ages
    40 and older
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Run by
    Brigham and Women's Hospital
  10. The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

    The aim of this Phase 3 study is to evaluate the efficacy of Kinisoquin™ as compared to the placebo in prevention of thromboembolic events in patients with metastatic or locally advanced pancreatic cancer.

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Ventura Clinical Trials, Ventura, California
    Locations
    3 in total
    Run by
    Quercis Pharma AG
  11. Venous Thromboembolism Prevention in Outpatients With Glioma

    This is an open label study of apixaban for venous thromboembolism prevention in patients with newly diagnosed grade 4 glioma.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    University of Vermont Medical Center, Burlington, Vermont
    Run by
    University of Vermont Medical Center
  12. PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism

    The PREP and GO study is an international multicentre prospective cohort evaluating anticoagulation management strategies around labor and delivery and the postpartum period.

    Stage
    Not phased
    Ages
    18 to 60
    Site
    Duke University Hospital, Durham, North Carolina
    Locations
    14 in total
    Run by
    University of Calgary
  13. Apixaban or Enoxaparin After Head and Neck Cancer Surgery

    The goal of this clinical trial is to learn if apixaban (a pill) is a safe and easier alternative to taking enoxaparin (a daily shot) to prevent blood clots after head and neck cancer surgery. It will also learn about side effects of both medicines. The main questions it aims to answer are: Can api…

    Stage
    Phase 4
    Ages
    18 to 89
    Site
    SUNY Upstate, Syracuse, New York
    Run by
    Kiranya Arnold
  14. Filter Initial & Long Term Evaluation After Placement and Retrieval Registry

    A prospective data registry for all patients who undergo IVC (Inferior Vena Cava) filter placement or retrieval at Stanford. Potential enrollees will already be undergoing the procedure. If patients are willing, they will be prospectively enrolled prior to the procedure. As part of the study, chart…

    Stage
    Not phased
    Ages
    Any age
    Site
    Stanford University School of Medicine, Stanford, California
    Run by
    Stanford University
  15. Supplemental Oxygen in Pulmonary Embolism (SO-PE)

    A study of how supplemental oxygen helps patients with acute pulmonary embolism (PE). Hypothesis: Oxygen affects right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (PE) primarily by relieving hypoxic pulmonary vasoconstriction and reducing pulmonary pressure (PA) pressure…

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Run by
    Massachusetts General Hospital

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.